Healthcare data platform developer Evidation Health took its total funding to $31m in a round led by Sanofi-Genzyme BioVentures that included GE Ventures.

Sanofi-Genzyme BioVentures, the strategic investment arm of pharmaceutical company Sanofi, has led a $10m funding round for US-based healthcare data analysis platform Evidation Health.

The round also featured GE Ventures, the corporate venturing vehicle formed by industrial product conglomerate General Electric, and B Capital Group, the venture capital fund formed by Facebook co-founder Eduardo Saverin.

Evidation has built a software platform that uses data collected from connected patients to analyse and quantify the effect of digital and other alternative treatment…